Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour

Nature Communications

Volumn 5, Issue , 2014, Pages

  Hanks, Sandra ^a   Perdeaux, Elizabeth R ^a   Seal, Sheila ^a   Ruark, Elise ^a   Mahamdallie, Shazia S ^a   Murray, Anne ^a   Ramsay, Emma ^a   Del Vecchio Duarte, Silvana ^a   Zachariou, Anna ^a   De Souza, Bianca ^a,b   Warren Perry, Margaret ^a   Elliott, Anna ^a   Davidson, Alan ^c   Price, Helen ^d   Stiller, Charles ^e   Pritchard Jones, Kathy ^f   Rahman, Nazneen ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d GREAT WESTERN HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE II; CTR9 PROTEIN, HUMAN; NUCLEAR PROTEIN; PAF1 PROTEIN, HUMAN; PHOSPHOPROTEIN;

CANCER; CHILD HEALTH; EMBRYO; GENE EXPRESSION; MUTATION; TUMOR;

ABDOMINAL MASS; ARTICLE; CARCINOGENESIS; CELL PLURIPOTENCY; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CLN THREE REQUIRING 9 GENE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENZYME REGULATION; EXOME; FAMILY; FEMALE; GENE SEQUENCE; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GERMLINE MUTATION; HEK293 CELL LINE; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEPHROBLASTOMA; ORGANOGENESIS; SANGER SEQUENCING; TUMOR SUPPRESSOR GENE; ALTERNATIVE RNA SPLICING; CYTOLOGY; DNA MUTATIONAL ANALYSIS; EXON; FAMILY HEALTH; GENETICS; INFANT; KIDNEY; LYMPHOCYTE; METABOLISM; PATHOLOGY; PEDIGREE; PRESCHOOL CHILD;

ALTERNATIVE SPLICING; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXOME; EXONS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INFANT; KIDNEY; LYMPHOCYTES; MALE; NUCLEAR PROTEINS; PEDIGREE; PHOSPHOPROTEINS; WILMS TUMOR;

EID: 84907342992     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5398     Document Type: Article

References (16)

1. Pritchard-Jones, K. et al. Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial. Ann. Oncol. 23, 2457-2463 (2012).
2. Scott, R. H., Stiller, C. A., Walker, L. & Rahman, N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J. Med. Genet. 43, 705-715 (2006). (Pubitemid 44483912)
3. Rahman, N. et al. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat. Genet. 13, 461-463 (1996). (Pubitemid 26256621)
4. McDonald, J. M. et al. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res. 58, 1387-1390 (1998). (Pubitemid 28193596)
5. Rapley, E. A. et al. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2. Br. J. Cancer 83, 177-183 (2000). (Pubitemid 30411714)
6. Ruark, E. et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 493, 406-410 (2013).
7. Jaehning, J. A. The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim. Biophys. Acta 1799, 379-388 (2010).
8. Tomson, B. N. & Arndt, K. M. The many roles of the conserved eukaryotic Paf1 complex in regulating transcription, histone modifications, and disease states. Biochim. Biophys. Acta 1829, 116-126 (2013).
9. Allan, R. K. & Ratajczak, T. Versatile TPR domains accommodate different modes of target protein recognition and function. Cell Stress Chaperones 16, 353-367 (2011).
10. Mueller, C. L. & Jaehning, J. A. Ctr9, Rtf1, and Leo1 are components of the Paf1/RNA polymerase II complex. Mol. Cell. Biol. 22, 1971-1980 (2002). (Pubitemid 34224606)
11. Akanuma, T., Koshida, S., Kawamura, A., Kishimoto, Y. & Takada, S. Paf1 complex homologues are required for Notch-regulated transcription during somite segmentation. EMBO Rep. 8, 858-863 (2007). (Pubitemid 350001430)
12. Ding, L. et al. A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4, 403-415 (2009).
13. Carpten, J. D. et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat. Genet. 32, 676-680 (2002). (Pubitemid 35435184)
14. Rich, T. A. GeneReviews (University of Washington, 2008; updated 2012).
15. Lunter, G. & Goodson, M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 21, 936-939 (2011).
16. Rimmer, A., Phan, H., Mathieson, I., Zamin, I., Twigg, S. R. F., WGS500 Consortium, Wilkie, A. O. M. & McVean, G. Integrating mapping-, assemblyand haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet. (2012).